Just a year ago I posted a short letter by microbiologist Tom Grier to governors and congressmen in Lyme endemic regions. You can read it here: https://madisonarealymesupportgroup.com/2019/08/25/open-letter-to-governors-congressmen-in-lyme-endemic-areas/ Today I post his lengthier letter explaining the state of affairs in simple lay-man’s terms that can be understood by all. This is a wonderful resource for you to save and refer to when explaining the science behind this horribly mishandled 21st century plague.
LTR to Congress (Letter here)
- Lyme disease is a collection of many species of bacteria, not just borrelia burgdorferi (Bb).
- Current testing uses only this one strain (B-31) therefore missing many cases. B-31 is not found in nature and is a created lab strain designed for cost, convenience, & consistency.
- Researchers are discovering approximately one new species a year to the existing 17 pathogenic borrelia species.
- There are numerous reasons patients are not testing positive on antibody testing such as: low infection load, different borrelia species, immune system ineffectiveness, borrelia quickly moves out of the blood stream and into human cells.
- It can take less than a day for Lyme to get into the brain.
- Mouse models show spirochetes entering tissues within minutes.
- Some species of Borrelia settle in the brain where it is safe behind the blood brain barrier which prevents drugs from entering.
- Borrelia forms protective biofilms also impeding antimicrobials from working.
- Brain-autopsies on dementia patients almost always show Borrelia in amyloid plagues.
- Borrelia infections can survive in a dormant state for decades.
- Regarding testing, each lab has a different cut off point for dilution.
- Independent researchers have found there are more false negatives than false positives.
- There are rife conflicts of interests within the CDC regarding Lyme testing as they own the patents.
- Borrelia Miyamotoi (Bm) can be transmitted in 20 minutes and autopies show it loves the human brain, and is associated with Alzheimer’s Dementia.
- Although Bm is similar to Bb, testing won’t pick it up.
- The CDC ignores the shortcomings of testing, the newer species of Borrelia, as well as Lyme-like diseases typically found in the South, and continues to use a one-size-fits-all approach.
I will add to this list the fact that the CDC besides only looking at one strain of borrelia, refuses to acknowledge coinfection involvement of other pathogens which research has shown to complicate cases making them more severe and of longer duration: https://madisonarealymesupportgroup.com/2019/09/05/babesia-subverts-adaptive-immunity-and-enhances-lyme-disease-severity/
Nearly every patient I work with is coinfected with numerous pathogens yet the CDC/NIH/IDSA refuse to acknowledge this. Researchers also are finding that ticks are also coinfected: https://madisonarealymesupportgroup.com/2017/05/18/powassan-and-bb-infection-in-wisconsin-and-u-s-tick-populations/
https://madisonarealymesupportgroup.com/2019/04/26/three-strains-of-borrelia-other-pathogens-found-in-salivary-glands-of-ixodes-ticks-suggesting-quicker-transmission-time/ Another false notion is that ticks have a “grace period” in which they don’t seemingly transmit infections to humans. This is asinine. Ticks often feed partially and then drop off. The pathogens are right in the salivary glands ready to be transmitted to the next unlucky host.